Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Becaplermin biosimilar - Adocia

Drug Profile

Becaplermin biosimilar - Adocia

Alternative Names: BC-PDGF-BB; BioChaperone® PDGF-BB; PDGF-BB biosimilar - Adocia

Latest Information Update: 23 Sep 2016

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Adocia
  • Class Blood proteins; Cicatrizants; Growth factors; Recombinant proteins
  • Mechanism of Action Platelet-derived growth factor receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes - Burns; Diabetic foot ulcer; Pressure ulcer; Varicose ulcer

Highest Development Phases

  • Discontinued Burns; Diabetic foot ulcer; Pressure ulcer; Varicose ulcer

Most Recent Events

  • 22 Sep 2016 Discontinued - Phase-III for Diabetic foot ulcer in India (Topical)
  • 16 Jul 2016 No recent reports of development identified for preclinical development in Burns in France (Topical, Spray)
  • 16 Jul 2016 No recent reports of development identified for preclinical development in Pressure-ulcer in France (Topical, Spray)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top